Firefly Luciferase CD20 Knockout Raji Cell Line

Firefly Luciferase CD20 Knockout Raji Cell Line
Item number Size Datasheet Manual SDS Delivery time Quantity Price
BPS-82624 2 vials - -

3 - 8 business days*

9,897.00€
 
Firefly Luciferase CD20 Knockout Raji Cell Line is a Raji cell line in which CD20 (B-lymphocyte... more
Product information "Firefly Luciferase CD20 Knockout Raji Cell Line"
Firefly Luciferase CD20 Knockout Raji Cell Line is a Raji cell line in which CD20 (B-lymphocyte antigen CD20, or MS4A1) has been genetically removed from Raji cells using CRISPR/Cas9 genome editing, while also constitutively expressing firefly (Photinus pyralis) luciferase under the control of a CMV promoter. This cell line was generated by using Firefly Luciferase Lentivirus (BPS Bioscience #79692) on CD20 Knockout Raji Cell Line (BPS Bioscience #82622). This cell line has been validated by genome sequencing, flow cytometry, and luciferase activity measurement.
Keywords: Bp35, CD20, MS4A1, B-lymphocyte antigen CD20, B-lymphocyte surface antigen B1, Leukocyte surface antigen Leu-16, Membrane-spanning 4-domains subfamily A member 1,
Supplier: BPS Bioscience
Supplier-Nr: 82624

Properties

Application: CAR-T / NK co-culture killing assay control, in vitro/in vivo bioluminescence Imaging
Species reactivity: human

Handling & Safety

Storage: Liquid nitrogen
Shipping: -80°C (International: °C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "Firefly Luciferase CD20 Knockout Raji Cell Line"
Write a review
or to review a product.
Viewed